Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Dikelele Elessa, MD, Stephanie Harel, MD, Alexis Talbot, MD, Marion Malphettes, MD, Catherine Thieblemont, MD PhD, Frederic Davi, MD PhD, Odile Maarek, MD, Bertrand Arnulf, MD PhD, Bruno Royer, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-137592

Published: 2020

Journal Articles

Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)

Blood (2019) 134 (Supplement_1): 2700.

https://doi.org/10.1182/blood-2019-127475

Published: 2019

Journal Articles

Intra-Tumor Heterogeneity in Acute Myeloid Leukemia (AML): Results from a Real Life Cohort

Blood (2018) 132 (Supplement 1): 1537.

https://doi.org/10.1182/blood-2018-99-111288

Published: 2018

Journal Articles

MDS with Isolated Trisomy 8. a Type of MDS Frequently Associated with Myeloproliferative Features? A Report from the GFM

Blood (2015) 126 (23): 2881.

https://doi.org/10.1182/blood.V126.23.2881.2881

Published: 2015

Journal Articles

ABCG2 Polymorphism Is Associated with Lower Major Molecular Response Rates in CML Patients Treated with 400 Mg Imatinib but Not in Patients Treated with 600 Mg Imatinib.

Marc Delord, Philippe Rousselot, MD, PhD, Jean-Michel Cayuela, Pascale Loiseau, Odile Maarek, Francois Sigaux, MD, Joelle Guilhot, PhD, Claude Preudhomme, Francois Guilhot, Fabien Calvo, Heriberto Bruzzoni-Giovanelli

Blood (2012) 120 (21): 2465.

https://doi.org/10.1182/blood.V120.21.2465.2465

Published: 2012

Journal Articles

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Jean-Baptiste Micol, Emmanuel Raffoux, MD, Nicolas Boissel, MD, PhD, Etienne Lengliné, MD, Emmanuel Canet, Thierry Leblanc, Marie-Thérèse Daniel, Adrienne de Labarthe, Odile Maarek, Bruno Cassinat, Christine Chomienne, MD, PhD, Lionel Adès, André Baruchel, Laurent Degos, Elie Azoulay, MD, PhD, Hervé Dombret

Blood (2010) 116 (21): 1083.

https://doi.org/10.1182/blood.V116.21.1083.1083

Published: 2010

Journal Articles

Trisomy 8 in the Light of Recent Cytogenetic Classification Advances. A Study From the French Acute Myeloid Leukemia Intergroup.

Nicolas Boissel, Christine Terré, Pascale Cornillet-Lefebvre, Odile Maarek, Eric Lippert, Isabelle Tigaud, Nicole Dastugue, Claude Preudhomme, Norbert Ifrah, MD, Hervé Dombret, Isabelle Luquet, MD, PhD

Blood (2009) 114 (22): 2594.

https://doi.org/10.1182/blood.V114.22.2594.2594

Published: 2009

Journal Articles

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

Emmanuel Raffoux, Adrienne de Labarthe, Audrey Cras, Christian Recher, Pascal Turlure, Jean-Pierre Marolleau, Oumedaly Reman, Claude Gardin, Sebastien Maury, Philippe Rousselot, Jean-Valère Malfuson, Odile Maarek, Laurent Degos, Christine Chomienne, Hervé Dombret

Blood (2008) 112 (11): 763.

https://doi.org/10.1182/blood.V112.11.763.763

Published: 2008

Journal Articles

Cranial Nerves Paralysis Revealing Two Cases of Histiocytic Sarcoma.

Lionel Galicier, MD, Florence Masson, MD, Antoine Moulignier, MD, Raphael Borie, MD, Jaqueline Mikol, MD, Veronique Meignin, MD, Odile Maarek, MD, Claire Fieschi, MD, Eric Oksenhendler, MD

Blood (2007) 110 (11): 4406.

https://doi.org/10.1182/blood.V110.11.4406.4406

Published: 2007

Journal Articles

Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial.

Christine Terré, Claude Gardin, Nathalie Gachard, Isabelle Tigaud, François Désangles, Christian Bastard, Odile Maarek, Jean-Luc Lai, Alain Bernheim, Christine Perot, Florence Nguyen-Khac, Virginie Eclache, Ghislaine Plessis, Pascal Turlure, Xavier Thomas, Thierry de Revel, Pierre Fenaux, Hervé Dombret

Blood (2007) 110 (11): 4233.

https://doi.org/10.1182/blood.V110.11.4233.4233

Published: 2007

Journal Articles

The Challenge of Diagnosing Fanconi Anemia in Patients with Bone Marrow Failure (BMF): A Study in 82 BMF Patients.

Fernando O. Pinto, MD, Thierry Leblanc, MD, Gwenaelle Le Roux, Jerome Larghero, PhD, Bruno Cassinat, MD, PhD, Moema Santos, MD, Benoit Brethon, MD, Caroline Oudot, MD, Odile Maarek, MD, Gerard Socie, MD, PhD, Andre Baruchel, MD, Eliane Gluckman, MD, Jean Soulier, MD, PhD

Blood (2006) 108 (11): 991.

https://doi.org/10.1182/blood.V108.11.991.991

Published: 2006

Journal Articles

Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia

Elise Chapiro, Lisa Russell, Isabelle Radford-Weiss, Christian Bastard, Michel Lessard, Stephanie Struski, Helene Cave, Sandra Fert-Ferrer, Carole Barin, Odile Maarek, Veronique Della-Valle, Jonathan C. Strefford, Roland Berger, Christine J. Harrison, Olivier A. Bernard, Florence Nguyen-Khac, the Groupe Francophone de Cytogénétique Hématologique

Blood (2006) 108 (10): 3560–3563.

https://doi.org/10.1182/blood-2006-03-010835

Published: 2006

Includes: Supplemental data

Journal Articles

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

Philippe Rousselot, Francoise Huguet, Delphine Rea, Laurence Legros, Jean Michel Cayuela, Odile Maarek, Odile Blanchet, Gerald Marit, Eliane Gluckman, Josy Reiffers, Martine Gardembas, François-Xavier Mahon, The Intergroupe Français des Leucémies Myéloïdes Chronique (FIφLMC)

Blood (2006) 109 (1): 58–60.

https://doi.org/10.1182/blood-2006-03-011239

Published: 2006

Journal Articles

Imatinib Mesylate Discontinuation in Patients with Chronic Myelogenous Leukaemia in Complete Molecular Remission for More Than Two Years.

Philippe Rousselot, MD, PhD, Françoise Huguet, MD, Jean Michel Cayuela, MD, PhD, Odile Maarek, MD, Gérald Marit, MD, Eliane Gluckman, MD, PhD, Josy Reiffers, MD, PhD, François X. Mahon, MD, PhD

Blood (2005) 106 (11): 1101.

https://doi.org/10.1182/blood.V106.11.1101.1101

Published: 2005

Journal Articles

ALFA-9000 Trial - An Analysis of Cytogenetic Subsets: Significant Long-Term Benefit of Early Induction Reinforcement Is Observed in CBF-AML Only.

Claude Gardin, Sylvie Chevret, Christiane Charrin, Xavier Thomas, Christian Bastard, Jean-Luc Lai, Odile Maarek, Stephane de Botton, Dominique Bordessoule, Herve Tilly, Thierry de Revel, Christine Terre, Claude Preudhomme, Francis Bauters, Mauricette Michallet, Denis Fiere, Sylvie Castaigne, Pierre Fenaux, Herve Dombret

Blood (2005) 106 (11): 1842.

https://doi.org/10.1182/blood.V106.11.1842.1842

Published: 2005

Journal Articles

A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)

Christiane Charrin, Xavier Thomas, Martine Ffrench, Quoc-Hung Le, Joris Andrieux, Marie-Joelle Mozziconacci, Jean-Luc Laï, Chrystele Bilhou-Nabera, Lucienne Michaux, Alain Bernheim, Christian Bastard, Hossein Mossafa, Christine Perot, Odile Maarek, Claude Boucheix, Véronique Lheritier, André Delannoy, Denis Fière, Nicole Dastugue

Blood (2004) 104 (8): 2444–2451.

https://doi.org/10.1182/blood-2003-04-1299

Published: 2004

NARROW

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)

Intra-Tumor Heterogeneity in Acute Myeloid Leukemia (AML): Results from a Real Life Cohort

MDS with Isolated Trisomy 8. a Type of MDS Frequently Associated with Myeloproliferative Features? A Report from the GFM

ABCG2 Polymorphism Is Associated with Lower Major Molecular Response Rates in CML Patients Treated with 400 Mg Imatinib but Not in Patients Treated with 600 Mg Imatinib.

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Trisomy 8 in the Light of Recent Cytogenetic Classification Advances. A Study From the French Acute Myeloid Leukemia Intergroup.

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

Cranial Nerves Paralysis Revealing Two Cases of Histiocytic Sarcoma.

Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial.

The Challenge of Diagnosing Fanconi Anemia in Patients with Bone Marrow Failure (BMF): A Study in 82 BMF Patients.

Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

Imatinib Mesylate Discontinuation in Patients with Chronic Myelogenous Leukaemia in Complete Molecular Remission for More Than Two Years.

ALFA-9000 Trial - An Analysis of Cytogenetic Subsets: Significant Long-Term Benefit of Early Induction Reinforcement Is Observed in CBF-AML Only.

A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only